FONDAPARINUX USAGE IN NON-ST-ELEVATION ACUTE CORONARY SYNDROME

Autor:	G. V. Mardaryan, S. A. Abugov
Jazyk:	ruština
Rok vydání:	2015
Předmět:	acute coronary syndrome nsteacs anticoagulation pci fondaparinux enoxaparin myocardial infarction bleeding Diseases of the circulatory (Cardiovascular) system RC666-701
Zdroj:	Российский кардиологический журнал, Vol 0, Iss 9, Pp 88-91 (2015)
Druh dokumentu:	article
ISSN:	1560-4071 2618-7620
DOI:	10.15829/1560-4071-2015-9-88-91
Popis:	Anticoagulation treatment is a vital component of acute coronary syndrome treatment. Selection of the most efficient and safe drug for the acute coronary syndrome patients without ST elevation (NSTEACS) depends on the strategy of treatment and is in fact a difficult task. Fondaparinux (Arixtra) is a synthetic Xa factor clotting inhibitor, has showed its benefits in clinical studies, according to which it is included into clinical guidelines. Current review focuses on the main results and conclusions of the studies, and the place for fondaparinux in clinical practice is described
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/ad1082f4450441afafd1d3685bb52cdd Zobrazit plný text záznamu View record in DOAJ